12:00 AM
May 28, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Plazomicin: Phase II data

Achaogen said a double-blind, international Phase II trial in 145 patients with cUTI or acute pyelonephritis showed that once-daily 15 mg/kg IV plazomicin for 5 days "met its objectives of assessing safety and efficacy" by demonstrating "favorable"...

Read the full 164 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >